Healthtech Summit Experts Outline Criteria for Diagnostic Labs and Predictive Tests

Experts and medical leaders examined criteria for selecting pathology laboratories and utilizing modern diagnostic tools at the Healthtech Summit. According to the reported discussions, panelists addressed risks associated with commercial testing packages and misleading marketing, urging patients to prioritize laboratory accreditation, physician supervision, quality control, and clinical history.

Key Panel Discussions and Recommendations

• Lab Selection and Oversight: Experts advised prioritizing accredited laboratories, quality control measures, and proper physician supervision.
• Lifestyle Disease Screenings: Discussions evaluated screenings for conditions such as diabetes and cardiovascular diseases while addressing the impacts of over-testing and missed diagnoses.
• Advanced Diagnostics: The summit explored predictive medicine, whole-body imaging, gut microbiome profiling, genetic sequencing, and coronary calcium scoring for disease risk stratification.
• Antimicrobial Resistance: Panellists called for replacing outdated diagnostics, such as the Widal test for typhoid, with targeted methodologies to reduce unnecessary antibiotic prescriptions.
• Artificial Intelligence: Sessions outlined the application of AI in radiology and pathology, noting that clinical algorithms serve as precision decision-support tools alongside specialist physicians.

Practical Implications and Verification

Patients and healthcare seekers are advised to consult qualified medical practitioners for pre-test counselling and clinical guidance before undergoing advanced diagnostic procedures. To verify original announcements and detailed guidelines from health summits, interested individuals should consult official medical council publications, accredited healthcare institution updates, or direct records from the event organizers.